Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:EC 1.3.1.* (oxidoreductase acting on donor CH-CH group, NAD(+) or NADP(+) as acceptor) inhibitor
go back to main search page
Accession:CHEBI:76857 term browser browse the term
Definition:An EC 1.3.* (oxidoreductase acting on donor CH-CH group) inhibitor that interferes with the action of any such enzyme using NAD(+) or NADP(+) as acceptor (EC 1.3.1.*).
Synonyms:related_synonym: EC 1.3.1.* (oxidoreductase acting on CH-CH group of donor with NAD(+) or NADP(+) as acceptor) inhibitors;   EC 1.3.1.* (oxidoreductase acting on CH-CH group of donor, NAD(+) or NADP(+) as acceptor) inhibitor;   EC 1.3.1.* (oxidoreductase acting on CH-CH group of donor, NAD(+) or NADP(+) as acceptor) inhibitors;   EC 1.3.1.* (oxidoreductase acting on donor CH-CH group, NAD(+) or NADP(+) as acceptor) inhibitors;   EC 1.3.1.* inhibitor;   EC 1.3.1.* inhibitors;   oxidoreductase acting on CH-CH group of donor with NAD(+) or NADP(+) as acceptor (EC 1.3.1.*) inhibitor


show annotations for term's descendants       view all columns           Sort by:
 

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 225
    role 225
      biological role 225
        biochemical role 186
          enzyme inhibitor 104
            EC 1.* (oxidoreductase) inhibitor 29
              EC 1.3.* (oxidoreductase acting on donor CH-CH group) inhibitor 3
                EC 1.3.1.* (oxidoreductase acting on donor CH-CH group, NAD(+) or NADP(+) as acceptor) inhibitor 0
                  EC 1.3.1.22 [3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+))] inhibitor + 0
                  EC 1.3.1.43 (arogenate dehydrogenase) inhibitor + 0
                  EC 1.3.1.70 (Delta(14)-sterol reductase) inhibitor + 0
                  EC 1.3.1.72 (Delta(24)-sterol reductase) inhibitor + 0
                  EC 1.3.1.8 [acyl-CoA dehydrogenase (NADP(+))] inhibitor + 0
                  EC 1.3.1.9 [enoyl-[acyl-carrier-protein] reductase (NADH)] inhibitor + 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.